Georgia Stem Cell Companies Banned From Marketing Treatments Following Misleading Ads
January 14, 2025
The co-founders of Stem Cell Institute of America, a Georgia stem cell clinic, have been
banned from marketing stem cell therapies after a federal court found they created and disseminated false and misleading advertisements about the efficacy and approval of these treatments.
The ruling, announced by the Federal Trade Commission and Georgia Attorney General’s Office last week, stems from a
2021 complaint against Steven D. Peyroux, Brent J. Detelich and several related companies. The court determined that Peyroux and Detelich falsely advertised unproven stem cell treatments for medical conditions like osteoarthritis and neuropathy, primarily targeting elderly and disabled patients. They marketed these treatments through misleading advertisements and seminars, costing patients up to $5,000 per injection.
The court’s order permanently prohibits the defendants from marketing or selling regenerative medicine treatments. A separate order requires them to pay more than $5.1 million in penalties and refunds for defrauded consumers.
